Novel Targeted Agents in Combination with R-MINE (RMINE+X) Based on Different Molecular Subtypes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma:a Phase 2 Multicenter Study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood

Topics

Medicine

Materials Science

Cancer Oncology

Immunology

Internal Medicine

Show all topics

DOI

10.1182/blood-2024-202967